BeOne Medicines director sells 31,028 depositary shares
The reported ADS sales were made under a Rule 10b5-1 plan adopted June 9, 2026, and the direct ordinary-share holding afterward was 4,588,113.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BeOne Medicines Ltd. director and Scientific Advisory Board Chair Xiaodong Wang reported exercising options covering 403,364 ordinary shares at an exercise price of $2.84 per share on October 27, 2026, and acquiring 31,028 American Depositary Shares (ADSs) at $36.90 per ADS. He sold 31,028 ADSs in 11 transactions that day; the reported weighted-average prices ranged from $355.5595 to $366.2205 per ADS. The sales were made under a Rule 10b5-1 trading plan adopted on June 9, 2026. The reported post-transaction position was 4,588,113 directly held ordinary shares, with zero shares remaining in the reported option position.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
13 txns
Insider
Wang Xiaodong
Role
Director
Sold
31,028 shs ($11.26M)
Approx. gross sale proceeds
$11.26M
Approx. exercise cost
$1.15M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option (Right to Buy) F17, F18 | 403,364 | $0.00 | $0.00 |
| Exercise | American Depositary Shares F4 | 31,028 | $36.90 | $1.14M |
| Sale | American Depositary Shares F4, F5, F6 | 880 | $355.5595 | $313K |
| Sale | American Depositary Shares F4, F5, F7 | 1,440 | $355.616 | $512K |
| Sale | American Depositary Shares F4, F5, F8 | 1,239 | $357.5386 | $443K |
| Sale | American Depositary Shares F4, F5, F9 | 1,681 | $358.7462 | $603K |
| Sale | American Depositary Shares F4, F5, F10 | 1,280 | $359.7219 | $460K |
| Sale | American Depositary Shares F4, F5, F11 | 320 | $360.6363 | $115K |
| Sale | American Depositary Shares F4, F5, F12 | 2,331 | $362.3503 | $845K |
| Sale | American Depositary Shares F4, F5, F13 | 8,148 | $363.242 | $2.96M |
| Sale | American Depositary Shares F4, F5, F14 | 2,841 | $363.9492 | $1.03M |
| Sale | American Depositary Shares F4, F5, F15 | 3,965 | $365.4293 | $1.45M |
| Sale | American Depositary Shares F4, F5, F16 | 6,903 | $366.2205 | $2.53M |
| Holding | Ordinary Shares | -- | -- | -- |
| Holding | Ordinary Shares F1 | -- | -- | -- |
| Holding | Ordinary Shares F2 | -- | -- | -- |
| Holding | Ordinary Shares F3 | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 0 contracts (Direct);
American Depositary Shares — 0 shares (Direct);
Ordinary Shares — 4,588,113 shares (Direct);
Ordinary Shares — 4,978,213 shares (Indirect, See Footnote)
Footnotes (18)
- F1. These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
- F2. These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F3. These securities are held by the spouse of the Reporting Person.
- F4. Each American Depositary Share represents 13 Ordinary Shares.
- F5. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.08 to $356.04, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.13 to $357.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.19 to $357.95, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.24 to $359.23, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.37 to $360.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.41 to $360.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.68 to $362.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.68 to $363.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.68 to $364.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.80 to $365.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.88 to $366.45, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F17. The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- F18. These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events.
Key Figures
Ordinary shares underlying options exercised: 403,364 ordinary shares
Option exercise price: $2.84 per ordinary share
ADSs acquired: 31,028 ADSs
+4 more
7 metrics
Ordinary shares underlying options exercised
403,364 ordinary shares
Reported October 27, 2026
Option exercise price
$2.84 per ordinary share
Options reported October 27, 2026
ADSs acquired
31,028 ADSs
Reported October 27, 2026
Reported acquisition price
$36.90 per ADS
ADS acquisition reported October 27, 2026
ADSs sold
31,028 ADSs
Across 11 transactions on October 27, 2026
Reported weighted-average sale prices
$355.5595–$366.2205 per ADS
Sale transactions reported October 27, 2026
Direct ordinary shares following transactions
4,588,113 ordinary shares
Reported after the October 27, 2026 transactions
Key Terms
Rule 10b5-1 trading plan, weighted average price, American Depositary Share, accelerated vesting
4 terms
Rule 10b5-1 trading plan regulatory
"The sale was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
accelerated vesting technical
"subject to accelerated vesting upon certain termination events"
A contract feature that makes stock awards, options, or restricted shares become owned or exercisable earlier than the original schedule. It shortens or cancels the waiting period so recipients can sell, transfer, or exercise their equity sooner — think of a timed lock that is unlocked ahead of schedule. It matters to investors because it changes when shares enter the market, who controls them, and how much dilution or ownership concentration happens.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ONC ADSs did Xiaodong Wang sell, and at what prices?
Xiaodong Wang sold 31,028 ADSs in 11 transactions on October 27, 2026, at reported weighted-average prices ranging from $355.5595 to $366.2205 per ADS. The sales were made under a Rule 10b5-1 trading plan adopted on June 9, 2026.
What vesting terms applied to the ONC options Xiaodong Wang exercised?
The options vested over four years: 25% on July 13, 2017, with the remainder in 36 successive equal monthly installments, subject to continued service. The footnote also states that unvested shares subject to the option were subject to accelerated vesting upon certain termination events.
AI-generated analysis. How Rhea-AI works. Not financial advice.
